0001237899-14-000034.txt : 20140318
0001237899-14-000034.hdr.sgml : 20140318
20140318170936
ACCESSION NUMBER: 0001237899-14-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140317
FILED AS OF DATE: 20140318
DATE AS OF CHANGE: 20140318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BROWN MICHAEL S
CENTRAL INDEX KEY: 0001174475
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 14701777
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-03-17
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001174475
BROWN MICHAEL S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2014-03-17
4
M
0
2000.0
33.42
A
16662
D
Common Stock
2014-03-17
4
S
0
1100.0
333.42
D
15562
D
Common Stock
2014-03-17
4
S
0
500.0
334.59
D
15062
D
Common Stock
2014-03-17
4
S
0
100.0
335.69
D
14962
D
Common Stock
2014-03-17
4
S
0
300.0
336.49
D
14662
D
Common Stock
2700
I
by Trust 2
Non-Qualified Stock Option (right to buy)
33.42
2014-03-17
4
M
0
2000.0
0.0
D
2021-01-03
Common Stock
2000
3000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 1,100 shares of Company stock on March 17, 2014 at prices ranging from $333.04 to $333.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on March 17, 2014 at prices ranging from $334.46 to $334.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Michael S. Brown
2014-03-17